Australia Stock Exchange release from AROVELLA THERAPE : Change of Director's Interest Notice x5
16/03/2022 06:53
Australia Stock Exchange release from AROVELLA THERAPE ALA.AX : Change of Director's Interest Notice x5
Recent news on Arovella Therapeutics
See all newsBrief: Arovella Therapeutics Appoints Acting CEO
Brief: Arovella Therapeutics Says Michael Baker Resigns As CEO
Brief: Arovella Therapeutics Says Elizabeth Stoner Will Be Retiring As Interim Chair
Brief: Arovella Therapeutics Says IND For Ala-101 Accepted By FDA
Brief: Arovella Therapeutics Appoints Lachie Mallia As CFO